All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
A six-year National Institutes of Health'sponsored study of 1,132 HIV-positive women who began antiretroviral treatment after progressing to late-stage HIV disease shows that anti-HIV drugs are helpful even for those who start treatment late. The study shows that low CD4-cell counts and high viral loads before beginning treatment are not predictive of weaker long-term responses to anti-HIV treatment as long as improvements in both measurements occur soon after therapy is initiated. U.S. treatment guidelines call for antiretroviral therapy to start when CD4-cell counts fall below 350 or HIV viral loads climb above 30,000. But many HIV-positive people do not learn that they are infected until they develop late-stage HIV disease. 'Prior to this study it was believed that many patients with advanced-stage HIV would not do very well with [highly active antiretroviral therapy],' notes Kathryn Anastos, principal investigator. 'Our study shows that is not the case.'
DON'T MISS THE OUT100 SPECIAL 3 DAY MARATHON STARTING NOVEMBER 24TH!
Journey through the year’s influential Out100 – the most iconic and long-standing celebration of LGBTQ+ icons and allies – in a 1-hour television special spotlighting the LGBTQ+ people shaping the world today.
WATCH & LIVESTREAM ON ADVOCATECHANNEL.COM
AND ON THE ADVOCATE CHANNEL APP
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Latest Stories
7 Uplifting Films To Celebrate Trans Awareness Week & Where To Stream Them
Out's Deal Guide: Grab Your 50% Off Amazon Fire Tablets & More Recommended Deals on Amazon Today!
Unlock Massive Savings at 'The Holiday Shop': Amazon's Hottest Deals of the Season Await!
Dianne Feinstein’s Commitment to People Living With HIV Won’t Be Forgotten
PEPFAR in Peril: The Far-Right Wants to End the Lifesaving Global HIV Program
Plus Nov/Dec Issue: PEPFAR in Danger & Our Allies and Advocates of the Year
Trending stories
Most Recent
Recommended Stories for You
Bob Adams
Editor
Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.
Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.